First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies

Sarina A. Piha-Paul, Kyaw Z. Thein, Paul De Souza, Richard Kefford, Tara Gangadhar, Christopher Smith, Shelly Schuster, William C. Zamboni, Claire E. Dees, Ben Markman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences